Group One Trading
UBX

Group One Trading’s Unity Biotechnology UBX Stock Holding History

Group One Trading’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,000
Closed -$1.04K – 8691
2025
Q1 		$1.04K Buy
+1,000
New +$1.81K ﹤0.01% 7166
2024
Q2 		– Sell
-10,000
Closed -$16.4K – 7523
2024
Q1 		$16.4K Sell
10,000
-200
-2% -$347 ﹤0.01% 5567
2023
Q4 		$19.7K Hold
10,200
– – ﹤0.01% 5761
2023
Q3 		$24.5K Buy
10,200
+8,100
+386% +$21.5K ﹤0.01% 5728
2023
Q2 		$5.36K Buy
+2,100
New +$5.55K ﹤0.01% 6687
2023
Q1 		– Sell
-12,700
Closed -$34.8K – 7994
2022
Q4 		$34.8K Buy
12,700
+11,920
+1,528% +$34.6K ﹤0.01% 5238
2022
Q3 		$3K Sell
780
-610
-44% -$3.85K ﹤0.01% 7051
2022
Q2 		$8K Sell
1,390
-810
-37% -$6.76K ﹤0.01% 6891
2022
Q1 		$25K Sell
2,200
-820
-27% -$9.2K ﹤0.01% 6620
2021
Q4 		$44K Buy
3,020
+1,880
+165% +$41.1K ﹤0.01% 6440
2021
Q3 		$34K Buy
1,140
+400
+54% +$14.1K ﹤0.01% 6838
2021
Q2 		$34K Buy
740
+40
+6% +$1.93K ﹤0.01% 6876
2021
Q1 		$42K Buy
700
+650
+1,300% +$44.3K ﹤0.01% 6351
2020
Q4 		$3K Sell
50
-9,140
-99% -$441K ﹤0.01% 6186
2020
Q3 		$318K Buy
9,190
+9,180
+91,800% +$581K ﹤0.01% 3266
2020
Q2 		$1K Buy
+10
New +$742 ﹤0.01% 5677
2019
Q3 		– Sell
-40
Closed -$4K – 5574
2019
Q2 		$4K Buy
+40
New +$3.4K ﹤0.01% 4654

Other funds holding UBX

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
AWM
AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return

Group One Trading's UBX Position: Q3 2025 in Review

Group One Trading sold out of Unity Biotechnology (UBX) in Q3 2025, closing a stake of 10,484 shares — an estimated $3.98K sold.

Group One Trading first reported a position in UBX in Q1 2019 and held it in 13 quarters. The position peaked at $188K in Q3 2020. 6 funds tracked by Wall St. Rank hold UBX as of Q3 2025.

  • Group One Trading reported no remaining Unity Biotechnology position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 10,484 Unity Biotechnology shares in Q3 2025, an estimated $3.98K.
  • Group One Trading first reported a position in Unity Biotechnology in Q1 2019 and held it in 13 quarters.
  • Group One Trading's Unity Biotechnology position peaked at $188K in Q3 2020.
  • 6 funds tracked by Wall St. Rank held Unity Biotechnology as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.